Skip to navigation Skip to content Skip to subnav
Searching 2019-2020 Session

2019-2020 Session

Change Session
Select a session

H.626

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Rep. George Till
House Committee on Health Care
1/10/2020 - Read First Time and Referred to the Committee on Health Care
Sponsor(s)
Location
House Committee on Health Care
Last Recorded Action
House 1/10/2020 - Read First Time and Referred to the Committee on Health Care
Bill/Resolution Text

NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Detailed Status

Regular Session 2019-2020
Body Date Journal Calendar Location Full Status
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Roll Call History

Regular Session 2019-2020
Body Date Journal Location Full Status

Back to top

Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Committee Meetings

Regular Session 2019-2020
Meeting Date Committee
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Meeting Full List

Regular Session 2019-2020
Friday, January 17, 2020
Committee(s):
House Committee on Health Care
-

H.626 - An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Rep. George W. Till, Sponsor

Thursday, January 30, 2020
Committee(s):
House Committee on Health Care
10:05 AM

H.626 - An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Rep. George W. Till, Sponsor
Jessica Chung, Resident from UVMMC

Committee Documents

An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Witnesses Who Testified

Regular Session 2019-2020
House Committee on Health Care
  • Jessica Chung, Resident from UVMMC
  • Rep. George W. Till, Sponsor

Back to top

Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill.  The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.

No fiscal documents found for H.626 in the Regular Session 2019-2020.
No committee of conference members found for H.626 in the Regular Session 2019-2020.
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Committee of Conference Meetings

Regular Session 2019-2020
Meeting Date Committee
An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Committee of Conference Meeting Full List

Regular Session 2019-2020
No committee of conference meeting history found for H.626 in the Regular Session 2019-2020.
No committee of conference report found for H.626 in the Regular Session 2019-2020.

Back to top

Act

No act information found for H.626 in the Regular Session 2019-2020.

Staff & Other Information

Staff
Jennifer Carbee, Deputy Chief Counsel

Back to top